National Cancer Institute; Notice of Closed Meeting, 44021 [2011-18566]
Download as PDF
Federal Register / Vol. 76, No. 141 / Friday, July 22, 2011 / Notices
instruments, contact George Chacko,
PhD. Center for Scientific Review, NIH,
Room 3030, 6701 Rockledge Drive,
Bethesda, MD 20892–7776, or call nontoll-free number 301–435–1133 or email your request, including your
address to: chackoge@csr.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
publication of the notice.
Dated: July 18, 2011.
George Chacko,
Director of Planning, Analysis, and
Evaluation, Center for Scientific Review,
National Institutes of Health.
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 18, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–18566 Filed 7–21–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2011–18617 Filed 7–21–11; 8:45 am]
Announcement of Requirements and
Registration for Using Public Data for
Cancer Prevention and Control: From
Innovation to Impact Developer
Challenge
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute,
National Institutes of Health, HHS.
ACTION: Notice.
AGENCY:
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Name of Committee: National Cancer
Institute Special Emphasis Panel, Childhood
Cancer Survivor Study.
Date: July 28, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 706, Rockville,
MD 20852, (Teleconference).
Contact Person: Marvin L. Salin, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 7073,
Bethesda, MD 20892–8329, 301–496–0694,
msalin@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
VerDate Mar<15>2010
17:59 Jul 21, 2011
Jkt 223001
The National Cancer Institute
(NCI), Division of Cancer Control and
Population Sciences (DCCPS), is
announcing the launch of the Using
Public Data for Cancer Prevention and
Control: From Innovation to Impact
Developer Challenge. This Challenge is
sponsored by the NCI and is presented
as part of the Office of the National
Coordinator for Health Information
Technology’s Investing in Innovation
(i2) program. This contest addresses the
NCI DCCPS mission to disseminate
information towards the prevention,
early detection, diagnosis, and treatment
and control of cancer. Specifically, the
contest supports the detection,
diagnosis, prevention, and treatment of
cancer through the demonstration of
new methods for the dissemination of
information to the general public
concerning the prevention, early
detection, diagnosis, and treatment and
control of cancer.
DATES: Important dates concerning the
two phases of the Challenge include the
following:
SUMMARY:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Phase I
Submission Period Begins: 12:01 a.m.,
EDT, July 20, 2011.
Submission Period for Initial Entries
Ends: 11:59 p.m., EDT, August 26, 2011.
Judging Process for Finalists Begins:
12:01 a.m., EDT, August 27, 2011.
Judging Process for Finalists Ends:
11:59 p.m., EDT, September 1, 2011.
Finalist(s) notified: September 2,
2011.
Finalist Demos at Health 2.0
Conference: September 25–27, 2011.
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
44021
Phase II
Final Submission Period Begins:
12:01 a.m., EDT, October 3, 2011.
Final Submission Period Ends: 11:59
p.m., EST, November 18, 2011.
Final Judging Process Begins: 12:01
a.m., EST, November 19, 2011.
Final Judging Process Ends: 11:59
p.m., EST, November 25, 2011.
Winner(s) notified: November 30,
2011.
Award Presentation at Hawaii
International Conference on System
Sciences (HICSS) Symposium: January
4, 2012.
FOR FURTHER INFORMATION CONTACT:
Abdul R. Shaikh, PhD, MHSc, Program
Director, Health Communication and
Informatics Research Branch, BRP,
DCCPS, National Cancer Institute,
Phone: 301–594–6690.
SUPPLEMENTARY INFORMATION:
Subject of Challenge Competition
Entrants are asked to develop software
applications (apps) that utilize the wide
array of health-related data made
available by the NCI DCCPS and other
Federal agencies for innovative
consumer health apps; these apps
should potentially integrate with
existing technology platforms and
address targets comprising DCCPS
priority areas on the continuum of
cancer prevention and control: https://
cancercontrol.cancer.gov/od/
index.html. Entrants are required to
address challenges faced by consumers,
clinicians, or researchers such as
behavior risk reduction for prevention/
survivorship (e.g., nutrition, physical
activity, smoking cessation), early
detection and screening, informed
decision-making, and adherence to
treatment regimens.
Eligibility Rules for Participating in the
Competition
To be eligible to win a prize under
this challenge, an individual or entity
shall have complied with all the
requirements under this section.
An individual or entity shall not be
deemed ineligible because the
individual or entity used Federal
facilities or consulted with Federal
employees during a competition if the
facilities and employees are made
available to all individuals and entities
participating in the competition on an
equitable basis.
This Challenge is open to any
Contestant, defined as (1) an individual
or team of U.S. citizens or permanent
residents of the United States who are
13 years of age and over (with the
permission of a parent/guardian if under
18 years of age), or (2) an entity
E:\FR\FM\22JYN1.SGM
22JYN1
Agencies
[Federal Register Volume 76, Number 141 (Friday, July 22, 2011)]
[Notices]
[Page 44021]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18566]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Childhood Cancer Survivor Study.
Date: July 28, 2011.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 706, Rockville, MD 20852, (Teleconference).
Contact Person: Marvin L. Salin, PhD, Scientific Review Officer,
Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694,
msalin@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to scheduling conflicts.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 18, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-18566 Filed 7-21-11; 8:45 am]
BILLING CODE 4140-01-P